SCHEMBL10580080

SCHEMBL10580080

CC(C)(CN)c1ccc2nc(-c3ccccn3)[nH]c2c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 8/20 0.75
▸ CBFB Q13951 12/20 0.67
▸ METAP1 P53582 6/20 0.61
▸ NPC1 O15118 5/20 0.61
▸ RAB9A P51151 5/20 0.61
▸ PKM P14618 4/20 0.61
▸ LMNA P02545 3/20 0.61
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ HPGD P15428 2/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ MAPT P10636 2/20 0.61
▸ TP53 P04637 1/20 0.61
▸ GAA P10253 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ RUNX1 Q01196 2/20 0.57
▸ F2 P00734 1/20 0.55
▸ F10 P00742 1/20 0.55
▸ F7 P08709 1/20 0.55
▸ MTOR P42345 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580068 0.90 METAP2 (0.60) METAP2CBFBMETAP1NPC1RAB9A
SCHEMBL10576089 0.82 NPBWR1 (0.64) METAP2NPC1RAB9ALMNASMN1; SMN2
SCHEMBL10695359 0.82 METAP2 (0.66) METAP2CBFBMETAP1NPC1RAB9A
SCHEMBL10695258 0.81 METAP2 (0.48) METAP2CBFBMETAP1NPC1RAB9A
SCHEMBL10579303 0.79 KDM4E (0.60) METAP2CBFBNPC1RAB9AHPGD
SCHEMBL10573947 0.79 NPC1 (0.58) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL10578018 0.77 DGAT1 (0.62) METAP2NPC1RAB9ALMNASMN1; SMN2
SCHEMBL4181882 0.77 METAP2 (0.81) METAP2CBFBMETAP1NPC1RAB9A
SCHEMBL4371835 0.76 METAP2 (1.00) METAP2CBFBMETAP1NPC1RAB9A
SCHEMBL12119033 0.76 CBFB (1.00) METAP2CBFBMETAP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback